Ameritas Investment Partners, Inc. Verastem, Inc. Transaction History

Ameritas Investment Partners, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $14,737 - $26,441	-14,449 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.69 - $4.2 $24,418 - $60,685	14,449 New	14,449 $25,000
Q2 2019 Aug 14, 2019	SELL	$1.25 - $3.14 $6,273 - $15,759	-5,019 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$6.86 - $9.97 $8,561 - $12,442	1,248 Added 33.09%	5,019 $36,000
Q2 2018 Aug 13, 2018	BUY	$2.88 - $8.67 $10,860 - $32,694	3,771 New	3,771 $26,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $628M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.